Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Caci International (CACI – Research Report), Telekom Austria (TKAGY – Research Report) and SEMrush Holdings (SEMR – Research Report).
Caci International (CACI)
In a report released yesterday, Seth Seifman from J.P. Morgan maintained a Buy rating on Caci International, with a price target of $310.00. The company’s shares closed last Tuesday at $289.73.
According to TipRanks.com, Seifman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Caci International with a $321.17 average price target, implying a 10.4% upside from current levels. In a report issued on October 31, Cowen & Co. also maintained a Buy rating on the stock with a $313.00 price target.
Telekom Austria (TKAGY)
In a report released today, Roman Arbuzov from J.P. Morgan maintained a Hold rating on Telekom Austria, with a price target of EUR6.80. The company’s shares closed last Tuesday at $12.25, close to its 52-week low of $11.26.
According to TipRanks.com, Arbuzov is ranked #1717 out of 8123 analysts.
Telekom Austria has an analyst consensus of Hold, with a price target consensus of $7.03.
SEMrush Holdings (SEMR)
J.P. Morgan analyst Mark Murphy maintained a Buy rating on SEMrush Holdings yesterday and set a price target of $15.00. The company’s shares closed last Tuesday at $10.01, close to its 52-week low of $7.41.
According to TipRanks.com, Murphy is a 5-star analyst with an average return of
Currently, the analyst consensus on SEMrush Holdings is a Strong Buy with an average price target of $16.33, implying a 30.8% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $14.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CACI:
- Immuron completes strategic investment in leading gut health biotech Ateria Health
- BurgerFi Reports Third Quarter 2022 Results
- Else Nutrition Launches on JD.com – China’s Largest E-tailer
- Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
- Verisk Earns Third Consecutive Great Place to Work Certification™ in the United Kingdom, Named a 2022 UK’s Best Workplace™ in Tech